Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_assertion description "[CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_assertion evidence source_evidence_curated NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_assertion SIO_000772 18086299 NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_assertion wasDerivedFrom ctd_human-2016 NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_assertion wasGeneratedBy ECO_0000218 NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.
- ctd_human-2016 importedOn "2016-01-25" NP20945.RAv8wcExBYGlAXehQJIFXv7w8c1W7toRFxvhg_N-LsZRI130_provenance.